Sophia Scheuermann

This study shows that using multiple adapter molecules in AdCAR-T cells can effectively target antigen-heterogeneous lymphoma by overcoming antigen-negative relapse.

This paper develops a mouse model for high-risk sarcoma by delivering genetic lesions via electroporation, generating multiple sarcoma types and validating their molecular and therapeutic relevance.